Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.

Díez-Campelo, María

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies. [electronic resource] - American journal of hematology Mar 2009 - 149-52 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.21340 doi


Adolescent
Adult
Aged
Cohort Studies
Flow Cytometry
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute--pathology
Middle Aged
Myelodysplastic Syndromes--pathology
Neoplasm Recurrence, Local
Neoplasm, Residual--pathology
Predictive Value of Tests
Survival Analysis
Transplantation, Homologous
Young Adult